This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Corporate

Apr. 25, 2013

Paul Hastings, Sidley guide $495 million collaboration

Paul Hastings LLP and Sidley Austin LLP represented Avalon Ventures and GlaxoSmithKline PLC, respectively, in a deal lawyers say bodes well for the struggling life science industry.


By Andrew McIntyre


Daily Journal Staff Writer


Paul Hastings LLP and Sidley Austin LLP represented La Jolla-based early-stage venture capital firm Avalon Ventures and U.K. pharmaceutical giant GlaxoSmithKline PLC, or GSK, respectively, in a $495 million collaboration between the companies, a deal announced Monday.


Lawyers involved heralded the deal - one of the largest of its kind - as indicative of an increasingly accepting attitude by large p...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up